Lysozyme [EC 3.2.1.17] derived from hen egg white stimulated immunoglobulin production by human-human hybridoma, HB4C5 cells producing human lung cancer specific monoclonal IgM. IgM production by HB4C5 cells was enhanced more than 13-fold by the addition of lysozyme at 380 g/ml in a serum-free medium. The immunoglobulin production stimulating effect of lysozyme was observed immediately after inoculation and maintained for 5 days. Lysozyme enhanced immunoglobulin production by the hybridoma line without growth promotion. This enzyme also accelerated IgM and IgG production of human peripheral blood lymphocytes 5.3-fold and 2.3-fold, respectively. These results suggest that lysozyme stimulates immunoglobuling production of not only specific hybridoma line, but also non-specific immunoglobulin producers. However, although the enzymatic activity of lysozyme was almost lost by heat-treatment at 100 C for 30 min, the IPSF activity was retained. This fact suggests that IPSF activity of lysozyme does not come from its enzymatic activity or reaction products. All these findings clearly indicate that lysozyme has a novel function as an immunoglobulin production stimulating factor.
Introduction
Monoclonal antibodies (MAbs) are applied to various fields, such as therapy, diagnosis, immunohistochemistry and also used for industrial applications to purify products by immunoaffinity chromatography. There are two strategies to produce MAbs in large quantities under serum-free conditions. One is the highdensity large-scale culture of hybridomas, and the other is the enhancement of immunoglobulin (Ig) productivity of hybridomas. We have demonstrated that there are substances termed Ig production stimulating factor (IPSF) which enhance Ig production by hybridomas and lymphocytes. IPSF-I purified from culture medium of human lymphoblastoid cell line, HO-323 was a 410 kDa macro-protein (Toyoda et al., 1990) . IPSF-II was found in cell extracts of Namalwa cells (Sugahara et al., 1991a) . IPSF-II contained two IPSF active substances, i.e. IPSF-II and -II. IPSF-II and II were completely purified and characterized as glyceraldehyde-3-phosphate dehydrogenase (GARPH) and enolase, respectively (Sugahara et al., 1991b and 1992) . IPSF-II stimulated Ig production by various human-human and mouse-mouse hybridomas 4-to 15-fold under serum-free conditions. Enzymatic activity in the glycolysis of GAPDH was not indispensable for expression of IPSF activity. Moreover, it was suggested that GAPDH stimulates posttranscriptional processes in protein synthesis to accelerate Ig production by hybridomas . Enolase identified as IPSF-II also stimulated Ig production by various hybridomas and human peripheral blood lymphocytes (PBL). These facts indicated that both GAPDH and enolase possess a novel biochemical function as IPSF, besider their enzymatic activity.
In addition, it was revealed that several basic proteins and poly-basic amino acids facilitated Ig production by hybridoma, HB4C5 cells (Sugahara et al., 1994) . These findings urged us to investigate IPSF activity of other basic proteins. As a result of screening, we found that lysozyme has IPSF activity against human-human hybridomas and human PBL. Lysozyme is a very simple and stable protein which has lower molecular weight (14 kDa) than other IPS-F's, and is easily separated from antibodies in culture medium by gel filtration. Moreover, this enzyme is so cheap that in practice it can be used for mass production of monoclonal antibodies. For these reasons, we investigated Ig production stimulating activity of lysozyme derived from hen egg white with a pI 10.5-11.0.
Material and methods

Lysozyme and its substrate
Lysozyme from hen egg white was purchased from Boehringer Mannheim (Germany), and dissolved in 10 mM sodium phosphate buffer (pH 7.4). This product gave single peak at 280 nm on HPLC gel filtration. Enzyme solution was sterilized by filtration before use. Micrococcus luteus, a substrate of lysozyme, was purchased from Sigma (USA).
Cells and cell culture
Human-human hybridoma HB4C5 cells which produce human lung cancer specific monoclonal IgM were used to assay IPSF activity of lysozyme. HB4C5 cells were fusion product of a human lymphocyte from lung cancer patient and a human fusion partner, NAT-30 (Murakami et al., 1985) . HB4C5 cells were cultured in ERDF medium (Kyokuto Pharmaceutical, Japan) supplemented with 10 g/ml of insulin, 20 g/ml of transferrin, 20 M of ethanolamine and 25 nM of selenite (ITES-ERDF) at 37 C under humidified 5% CO 2 -95% air (Murakami et al., 1982) .
Human PBL were freshly obtained from peripheral blood of a healthy donor before use. Peripheral blood diluted with equal volume of phosphate buffered saline was centrifuged at room temperature for 30 min on lymphocyte separation medium (Organon Teknika, USA). Following the washing with ERDF medium 3 times, PBL were pre-cultured in ERDF supplemented with 10% of fetal bovine serum for 1 day to remove ahesion-dependent cells such as monocytes. After preculture, PBL were inoculated in ITES-ERDF medium containing lysozyme to determine IPSF activity of lysozyme against human PBL.
Assay of IPSF activity of lysozyme
IPSF activity was examined by measuring the amount of Ig secreted by HB4C5 cells or human PBL in culture media. HB4C5 cells and human PBL were inoculated in ITES-ERDF medium containing lysozyme. The assay of IPSF activity was performed in a 96-well culture plate of which culture volume is 200 l/well.
HB4C5 cells and human PBL were inoculated at 110 5 cells/ml and 110 6 cells/ml, respectively. After cultivation in CO 2 -incubator at 37 C, the amount of Ig secreted in each culture medium was determined by enzyme-linked immunosorbent assay (ELISA) using anti-human IgM or IgG antibody (TAGO, USA) as mentioned in previous report (Sugahara et al., 1994) . Determination of IPSF activity of lysozyme was triplicated.
Assay of enzymatic activity of lysozyme
Enzymatic activity of lysozyme against Micrococcus luteus, a substrate of lysozyme, was turbidimetrically determined. M. luteus was suspended in 0.05 M sodium phosphate buffer (pH 7.0) to give an approximate absorbance 1.0 at 530 nm. Lysozyme was added to the substrate solution at 16 g/ml, and the enzymatic reaction was performed for 5 min at room temperature. The decrease of absorbance at 530 nm due to digestion of M. luteus by lysozyme was determined.
Results
Effect of lysozyme on IgM production by HB4C5 cells
Hybridoma HB4C5 cells were cultured in ITES-ERDF medium supplemented with lysozyme at various concentrations for 6 h to investigate a dose-response effect of lysozyme. After cultivation in a CO 2 -incubator, the amount of IgM secreted by HB4C5 cells in each culture medium was measured by ELISA. As shown in Fig. 1 , IgM production by HB4C5 cells was stimulated dose-dependently by the addition of lysozyme. HB4C5 cells were allowed to produce about 72 ng/ml of IgM in the presence of 380 g/ml of lysozyme dur- ing 6 h. This result discloses that lysozyme facilitates IgM production more than 13-fold as compared with that in ITES-ERDF medium.
Time-course effect of lysozyme on IgM production by HB4C5 cells
It was clearly demonstrated that lysozyme stimulates IgM production by HB4C5 cells during 6-h cultivation. Then, the time-course of the IPSF effect of lysozyme was examined. HB4C5 cells were inoculated in ITES-ERDF medium containing 380 g/ml of lysozyme. As indicated in Fig. 2 , lysozyme immediately started to enhance IgM production by HB4C5 soon after inoculation. Then the amount of IgM in the culture medium was linearly increased, and the IPSF effect was maintained throughout the culture period.
Moreover, a long-term effect of lysozyme on cell growth and IgM production of HB4C5 cells were investigated. HB4C5 cells were inoculated at 110 5 cells/ml in ITES-ERDF medium with or without 380 g/ml of lysozyme for 5 days. Lysozyme, however, showed no significant growth promoting activity toward HB4C5 cells, despite accelerated IgM production as shown in Fig. 3 . IgM production was facilitated more than 10-fold by this enzyme at the 4th day after inoculation. This result also suggests that lysozyme stimulates specific IgM productivity of HB4C5 cells.
Effect of lysozyme on Ig production by human PBL
Human PBL were inoculated at 110 6 cells/ml in ITES-ERDF medium supplemented with lysozyme to investigate the IPSF effect on IgM and IgG production by human PBL. Table 1 indicates the cell numbers and Ig levels in the culture medium after 4 days. The addition of 380 g/ml of lysozyme in the serum-free medium resulted in an increase in IgM and IgG production by human PBL. Production of IgM by PBL was enhanced 5.3-fold, and that of IgG by 2.3-fold. These findings indicate that this enzyme has an aptitude to facilitate Ig production by not only for specific hybridomas, but also for non-specific Ig producers. 
Heat and pH stability of lysozyme as IPSF
Lysozyme in 10 mM sodium phosphate buffer (pH 7.4) was boiled for 30 min to determine heat stability of IPSF and enzymatic activities. After ice-cooling, the enzymatic and IPSF activities were assayed. HB4C5 cells were cultured at 110 5 cells/ml for 6 h in ITES-ERDF medium supplemented with heat-treated or nontreated lysozyme. Lysozyme, however, lost its enzy- Lysozyme was heat-treated at 100 C for 30 min. For assay of IPSF activity, HB4C5 cells were inoculated at 110 5 cells/ml in ITES-ERDF medium containing 380 g/ml of each lysozyme sample, and cultured for 6 h. For assay of enzymatic activity, each lysozyme sample was added to substrate solution at 16 g/ml. After 5 min-incubation at room temperature, absorbance at 530 nm was measured. IPSF activity and enzymatic activity are expressed as relative activity against native lysozyme.
matic activity by boiling, IPSF activity was retained as shown in Table 2 . For analysis of pH stability, lysozyme was incubated in various pH buffer solutions for 12 h at 4 C. As indicated in Fig. 4 , both IPSF activity and enzymatic activity were remarkably stable in a wide pH range, and showed the same features against pH treatment. This fact simultaneously suggests that the IPSF activity of the lysozyme preparation used here is not derived from contaminants except for lysozyme.
Discussion
IPSF stimulates Ig production of hybrisomas and lymphocytes under serum-free conditions. Ig production by hybridomas in serum-free media supplemented with IPSF is superior to that in serum-supplemented media with or without IPSF (Murakami, et al., 1993) . Some substances have been identified as IPSF. We previously demonstrated that IPSF-II and -II in Namalwa cell lysate were glycolysis enzymes, GAPDH and enolase, respectively. GAPDH has been studied by many workers for its functions other than enzymatic activity (Sabath et al., 1990 , Nagy et al., 1995 and Singh et al., 1995 . GAPDH is also a protein having a binding affinity with nucleic acids, such as single stranded DNA, RNA, and mono-and polyribosomes (Perucho et al., 1977 , Perucho et al., 1980 , and Ryazanov et al., 1988 . Moreover, GAPDH is a one of the three major RNA-binding proteins in rabbit reticulocyte lysate (Ryazanov, 1985) . We predicted from these findings that a relationship exists between IPSF activity and nucleic acid binding activity. The IPSF activity of some nucleic acid binding proteins were assessed. The result was that lysine-rich histone (H1, H2A and H2B) and poly-lysine stimulated IgM production by hybridomas (Sugahara et al., 1994) .
Another common feature of these IPSF's including GAPDH and enolase, is basicity of the proteins. We thus paid attention to basic proteins as Ig production stimulating factor, and screened various basic proteins. Here we demonstrated the Ig production stimulating activity of lysozyme [EC 3.2.1.17] . Lysozyme from hen egg white remarkably enhanced Ig production by human-human hybridoma HB4C5 cells and human PBL under the serum-free conditions. Lysozyme accelerated IgM production by HB4C5 cells in ITES-ERDF medium more than 13-fold. HB4C5 cells were facilitated in their IgM production by lysozyme immediately after inoculation, and the IPSF effect was maintained for 5 days without growth promotion. These facts clearly indicate that lysozyme stimulates specific IgM productivity of the cell. Lysozyme also enhanced IgM and IgG productivity of human PBL 5.3-fold and 2.3-fold, respectively. It is assumed from this result that lysozyme in serum contributes not only to digestion of infectious microorganisms, but also accelerates immune responses in vivo.
Enzymatic and IPSF activities of lysozyme were examined after 100 C treatment for 30 min. However the enzymatic activity was almost lost, lysozyme stimulated IgM production by HB4C5 cells. This fact makes it clear that the IPSF activity of lysozyme is derived from neither its enzymatic activity nor reaction products. This result also provides an indication that this enzyme has a novel function other than enzymatic one.
Lysozyme is a extremely stable, and lower molecular weight protein in comparison with other IPSF proteins. This feature of lysozyme contributes not only to practical use for mass-production of monoclonal antibodies, but also to investigation of the mode of action as IPSF. We have some data implying that lysozyme stimulates post-transcriptional process in the same was as GAPDH and enolase (unpublished data). Uncovering the mode of action of lysozyme as IPSF will contribute to the effective enhancement of cellular productivity of Ig by hybridomas and lymphocytes.
